Elisabeth Kenne Sarenmalm1, Maria Browall2, Fannie Gaston-Johansson3. 1. Research and Development Centre, Skaraborg Hospital, Skövde, Sweden; Institute of Health and Caring Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: elisabeth.kenne.sarenmalm@vgregion.se. 2. Johns Hopkins University, Baltimore, Maryland, USA; School of Life Sciences, University of Skövde, Skövde, Sweden; Institute of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institute, Stockholm, Sweden. 3. Johns Hopkins University, School of Nursing, Baltimore, Maryland, USA.
Abstract
CONTEXT: Although there has been a growing interest in cancer symptom clusters, less is known about symptom burden clusters. OBJECTIVES: To explore clusters of burdensome symptoms over time, the impact on health status and quality of life, and coping capacity in patients with breast cancer. METHODS: In this longitudinal study, a sample of 206 patients completed the Memorial Symptom Assessment Scale, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, and the Sense of Coherence scale, at diagnosis of primary or recurrent breast cancer, and at one-, three-, and six-month follow-ups. RESULTS: Three clusters of burdensome symptoms were identified: emotional symptom burden, gastrointestinal symptom burden, and unwellness symptom burden. Most burdensome were emotional symptoms, with worrying, feeling sad, and feeling nervous as the core or defining symptoms. Over time, additional symptoms escalated the emotional symptom burden. The gastrointestinal symptom burden, with "change in the way food tastes" as a core symptom, was more often associated with chemotherapy. Less stable over time, the unwellness symptom burden could be interpreted as short- and long-term side effects of hormonal therapy. Of these clusters, only the emotional symptom burden cluster significantly diminished health status and quality of life. Patients reporting lower coping capacity experienced higher levels of symptom burden. CONCLUSION: This study provides insights into symptom burden clusters over time. A challenging approach toward symptom management in clinical oncology is to target the burden of a symptom cluster and to recognize the need for individually designed interventions to ameliorate symptom burden in cancer patients.
CONTEXT: Although there has been a growing interest in cancer symptom clusters, less is known about symptom burden clusters. OBJECTIVES: To explore clusters of burdensome symptoms over time, the impact on health status and quality of life, and coping capacity in patients with breast cancer. METHODS: In this longitudinal study, a sample of 206 patients completed the Memorial Symptom Assessment Scale, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, and the Sense of Coherence scale, at diagnosis of primary or recurrent breast cancer, and at one-, three-, and six-month follow-ups. RESULTS: Three clusters of burdensome symptoms were identified: emotional symptom burden, gastrointestinal symptom burden, and unwellness symptom burden. Most burdensome were emotional symptoms, with worrying, feeling sad, and feeling nervous as the core or defining symptoms. Over time, additional symptoms escalated the emotional symptom burden. The gastrointestinal symptom burden, with "change in the way food tastes" as a core symptom, was more often associated with chemotherapy. Less stable over time, the unwellness symptom burden could be interpreted as short- and long-term side effects of hormonal therapy. Of these clusters, only the emotional symptom burden cluster significantly diminished health status and quality of life. Patients reporting lower coping capacity experienced higher levels of symptom burden. CONCLUSION: This study provides insights into symptom burden clusters over time. A challenging approach toward symptom management in clinical oncology is to target the burden of a symptom cluster and to recognize the need for individually designed interventions to ameliorate symptom burden in cancerpatients.
Authors: Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden Journal: J Natl Cancer Inst Date: 2017-01-24 Impact factor: 13.506
Authors: Fannie Gaton-Johansson; Crystal C Watkins; Iye Kamara Kanu; Erin Whitehouse; Elisabeth Kenne Sarenmalm; Maria Brovall; Sharon L Kozachik Journal: J Natl Black Nurses Assoc Date: 2015-12
Authors: Laura C Pinheiro; Xianming Tan; Andrew F Olshan; Stephanie B Wheeler; Katherine E Reeder-Hayes; Cleo A Samuel; Bryce B Reeve Journal: Qual Life Res Date: 2017-02-28 Impact factor: 4.147
Authors: Sarah L Kerns; Chunkit Fung; Patrick O Monahan; Shirin Ardeshir-Rouhani-Fard; Mohammad I Abu Zaid; AnnaLynn M Williams; Timothy E Stump; Howard D Sesso; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair Beard; Robert A Huddart; Jeri Kim; Christian Kollmannsberger; Deepak M Sahasrabudhe; Ryan Cook; Sophie D Fossa; Lawrence H Einhorn; Lois B Travis Journal: J Clin Oncol Date: 2018-04-04 Impact factor: 44.544
Authors: Raymond C Tait; Kim Zoberi; McKenzie Ferguson; Kimberly Levenhagen; Rebecca A Luebbert; Kevin Rowland; Gretchen B Salsich; Christopher Herndon Journal: J Pain Date: 2018-06-30 Impact factor: 5.820
Authors: Elisabeth Kenne Sarenmalm; Lena B Mårtensson; Bengt A Andersson; Per Karlsson; Ingrid Bergh Journal: Cancer Med Date: 2017-04-18 Impact factor: 4.452
Authors: Maria Browall; Yvonne Brandberg; Salmir Nasic; Per Rydberg; Jonas Bergh; Andreas Rydén; Hanjing Xie; Irene Eriksson; Yvonne Wengström Journal: Support Care Cancer Date: 2016-12-15 Impact factor: 3.603
Authors: Charles Cleeland; Roger von Moos; Mark S Walker; Yuanyuan Wang; Jianqing Gao; Mariana Chavez-MacGregor; Alexander Liede; Jorge Arellano; Arun Balakumaran; Yi Qian Journal: Support Care Cancer Date: 2016-03-29 Impact factor: 3.603